Fifth disease - Bosgarren Gaixotasuna
☆ Alemaniako Stiftung Warentest-en 2022ko emaitzetan, ModelDerm-ekin kontsumitzaileen gogobetetasuna apur bat txikiagoa izan zen ordaindutako telemedikuntzako kontsultekin baino.
Bosgarren Gaixotasuna (Fifth disease) duen 16 hilabetekoa ― Bi masailak gorritu egiten dira, zaplaztekoak izango balira bezala, eta gorputzean erupzio maculopapularrak agertzen dira.
Eritema bi masailetan.
References
Fifth disease , eritema infekziosoa izenez ere ezaguna, B19 giza parbobirusak eragindako infekzio birikoa da. Haurretan nagusiagoa da, normalean 4 eta 14 urte bitartekoei eragiten die. Sintomak sarritan sukar arina, buruko mina, eztarriko mina eta gripearen antzeko sentimenduekin hasten dira. Haurrek slapped cheeks antzeko erupzio gorri bat sor dezakete aurpegian, gorputzean, besoetan eta hanketan erupzio eredu batekin batera. Helduetan, artikulazioetako mina ohiko kexa da, hasierako infekziotik aste batzuetara ager daitekeena. Nabarmentzekoa, B19 parbobirusarekin kutsatutako helduen % 20 eta 30 inguruk ez dute sintomarik erakutsi.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Parvovirus B19 amatik haurra pasatzeko arriskua % 33 ingurukoa da, eta kutsatutako emakumeen % 3 inguruk konplikazioak izaten dituzte haurtxoetan. Ama haurdunaldiaren 20 aste baino lehen kutsatzen denean, haurraren gorputzean odol-arazoak eta likidoak pilatzea bezalako konplikazioak izateko aukerak areagotu egiten dira. Gaixotasun hau kudeatzen hasteko, pazientea parbobirusaren eraginpean egon ote den egiaztatu beharko genuke antigorputz (IgM) batzuen probak eginez. Probak iraganeko esposiziorik erakusten ez badu baina duela gutxi infekzio bat adierazten badu, pazienteak arreta zorrotza behar du haurdunaldian, aldizkako ultrasoinu azterketak barne haurtxoaren osasun arazo jakin batzuk egiaztatzeko.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
bosgarren gaixotasuna (fifth disease) maila baxuko sukarra, buruko mina, erupzioa eta hotzeriaren antzeko sintomekin hasten da, hala nola sudurra jaria edo estua. Sintoma hauek igarotzen dira, eta egun batzuk geroago, erupzioa agertzen da. Erupzio gorri distiratsua aurpegian agertzen da gehienetan, batez ere masailetan. (hortik "masailaren gaixotasuna" izena). Masail gorriez gain, umeek sarritan erupzio gorri eta parpail bat sortzen dute gainerako gorputzean, goiko besoak, enborra eta hankak izaten dira ohikoenak.
Gaixotasuna arina izan ohi da, baina haurdun dauden emakumeengan, lehenengo hiruhilekoan infekzioa hidrops fetalisarekin lotuta egon da, eta berez abortu egiten du.
○ Tratamendua
Ez da tratamendu espezifikorik behar, normalean denborarekin hobetzen baita.